ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 169 filers reported holding ALKERMES PLC in Q2 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,702,750 | -13.3% | 275,000 | -3.2% | 1.07% | -3.2% |
| Q2 2023 | $8,889,200 | +76.2% | 284,000 | +58.7% | 1.10% | +8.4% |
| Q1 2023 | $5,046,010 | +13.0% | 179,000 | -10.5% | 1.02% | +17.1% |
| Q3 2022 | $4,466,000 | -42.8% | 200,000 | -23.7% | 0.87% | -45.9% |
| Q2 2022 | $7,804,000 | +18.6% | 261,966 | +4.8% | 1.60% | -6.2% |
| Q1 2022 | $6,578,000 | +465.6% | 250,000 | +400.0% | 1.71% | +431.7% |
| Q4 2021 | $1,163,000 | -68.4% | 50,000 | -66.7% | 0.32% | -68.2% |
| Q2 2021 | $3,678,000 | +70.0% | 150,000 | 0.0% | 1.01% | +6.3% |
| Q1 2020 | $2,163,000 | – | 150,000 | – | 0.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |